Marpai (MRAI) Competitors $1.37 -0.01 (-0.72%) As of 08/22/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. QIPT, EUDA, NAKA, SERA, KDLY, ATPC, BDSX, PIII, BMGL, and CCMShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Quipt Home Medical (QIPT), EUDA Health (EUDA), KindlyMD (NAKA), Sera Prognostics (SERA), Kindly MD (KDLY), Agape ATP (ATPC), Biodesix (BDSX), P3 Health Partners (PIII), Basel Medical Group (BMGL), and Concord Medical Services (CCM). These companies are all part of the "healthcare" industry. Marpai vs. Its Competitors Quipt Home Medical EUDA Health KindlyMD Sera Prognostics Kindly MD Agape ATP Biodesix P3 Health Partners Basel Medical Group Concord Medical Services Quipt Home Medical (NASDAQ:QIPT) and Marpai (NASDAQ:MRAI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Do analysts rate QIPT or MRAI? Quipt Home Medical currently has a consensus target price of $3.15, indicating a potential upside of 46.51%. Given Quipt Home Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Quipt Home Medical is more favorable than Marpai.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quipt Home Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Marpai 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable valuation and earnings, QIPT or MRAI? Quipt Home Medical has higher revenue and earnings than Marpai. Quipt Home Medical is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuipt Home Medical$245.91M0.38-$6.76M-$0.24-8.96Marpai$34.87M0.68-$28.75M-$0.87-1.57 Is QIPT or MRAI more profitable? Quipt Home Medical has a net margin of -4.30% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Quipt Home Medical's return on equity.Company Net Margins Return on Equity Return on Assets Quipt Home Medical-4.30% -9.78% -4.23% Marpai -85.70%N/A -100.23% Which has more volatility & risk, QIPT or MRAI? Quipt Home Medical has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Comparatively, Marpai has a beta of 4.66, meaning that its stock price is 366% more volatile than the S&P 500. Do institutionals and insiders have more ownership in QIPT or MRAI? 42.9% of Quipt Home Medical shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 13.4% of Quipt Home Medical shares are held by insiders. Comparatively, 46.1% of Marpai shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to QIPT or MRAI? In the previous week, Quipt Home Medical had 9 more articles in the media than Marpai. MarketBeat recorded 9 mentions for Quipt Home Medical and 0 mentions for Marpai. Quipt Home Medical's average media sentiment score of 0.98 beat Marpai's score of 0.00 indicating that Quipt Home Medical is being referred to more favorably in the media. Company Overall Sentiment Quipt Home Medical Positive Marpai Neutral SummaryQuipt Home Medical beats Marpai on 10 of the 16 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$23.66M$133.89M$24.33B$9.58BDividend YieldN/AN/A2.83%4.10%P/E Ratio-0.521.2228.3826.04Price / Sales0.680.6039.12103.40Price / CashN/A2.8025.7858.48Price / Book-0.800.256.026.61Net Income-$28.75M$43.11M$197.30M$265.56M7 Day Performance-4.86%120.20%1.54%1.97%1 Month Performance3.01%122.82%-2.40%-0.36%1 Year Performance199.39%102.44%32.84%19.03% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.37-0.7%N/A+199.4%$23.66M$34.87M-0.52150Gap DownQIPTQuipt Home Medical3.3475 of 5 stars$2.17-4.0%$3.15+45.2%-21.8%$98.18M$245.91M-9.041,200Analyst ForecastGap UpEUDAEUDA HealthN/A$2.31-12.5%N/A-43.8%$98.09M$4.01M0.002Positive NewsGap UpNAKAKindlyMDN/A$10.62-11.6%N/AN/A$90.72M$2.72M-12.35N/ANews CoverageSERASera Prognostics1.0785 of 5 stars$2.25-5.5%N/A-66.3%$89.66M$80K-2.65120News CoverageKDLYKindly MDN/A$12.02-12.1%N/A+525.3%$72.38M$2.47M-15.61N/APositive NewsATPCAgape ATP0.2475 of 5 stars$1.28-2.3%N/A-32.5%$65.51M$1.32M-3.1240News CoverageShort Interest ↑Gap DownBDSXBiodesix2.9793 of 5 stars$0.41-4.3%$1.75+330.3%-74.2%$62.32M$71.32M-1.40220PIIIP3 Health Partners2.2767 of 5 stars$7.17+3.2%$16.25+126.6%-70.8%$49.96M$1.50B-0.16500Short Interest ↑BMGLBasel Medical GroupN/A$1.91-8.6%N/AN/A$38.57MN/A0.0036Lockup ExpirationGap DownCCMConcord Medical ServicesN/A$5.44+2.3%N/A-21.5%$23.08M$52.60M0.00970Negative News Related Companies and Tools Related Companies Quipt Home Medical Competitors EUDA Health Competitors KindlyMD Competitors Sera Prognostics Competitors Kindly MD Competitors Agape ATP Competitors Biodesix Competitors P3 Health Partners Competitors Basel Medical Group Competitors Concord Medical Services Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access